Lv4
500 积分 2024-05-22 加入
TROP2 Promotes Tumor Cell Migration through Downregulation of DSG2 Revealed by Super-Resolution Fluorescence Imaging
1个月前
已完结
Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 study
1个月前
已完结
Single–amino acid variants in target epitopes can confer resistance to antibody-based therapies
1个月前
已完结
Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control
1个月前
已完结
Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis
1个月前
已完结
The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement
1个月前
已完结
Sacituzumab Tirumotecan in Participants With Advanced or Metastatic Urothelial Carcinoma and Disease Progression after Chemotherapy and Immune Checkpoint Inhibitors
1个月前
已完结
Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development
1个月前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study
1个月前
已完结
A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1
1个月前
已完结
皖公网安备34019202002308
